TY  - JOUR
AU  - Mingot-Castellano, María Eva
AU  - Bastida, José María
AU  - Caballero-Navarro, Gonzalo
AU  - Entrena Ureña, Laura
AU  - González-López, Tomás José
AU  - González-Porras, José Ramón
AU  - Butta, Nora
AU  - Canaro, Mariana
AU  - Jiménez-Bárcenas, Reyes
AU  - Gómez Del Castillo Solano, María Del Carmen
AU  - Sánchez-González, Blanca
AU  - Pascual-Izquierdo, Cristina
AU  - On Behalf Of The Gepti,
PY  - 2022
DO  - 10.3390/ph15070779
SN  - 1424-8247
UR  - http://hdl.handle.net/10668/21535
T2  - Pharmaceuticals (Basel, Switzerland)
AB  - Primary immune thrombocytopenia (ITP) is an autoimmune disorder that causes low platelet counts and subsequent bleeding risk. Although current corticosteroid-based ITP therapies are able to improve platelet counts, up to 70% of subjects with an ITP...
LA  - en
KW  - autoantibodies
KW  - immune thrombocytopenia
KW  - platelets
KW  - targeted therapies
KW  - thrombopoietin
TI  - Novel Therapies to Address Unmet Needs in ITP.
TY  - research article
VL  - 15
ER  -